SONAL CHOUDHARY: Open Payments
NPI 1598064248 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$27,520 in 61 payments from 10 companies in 2025. Trend: 2023 $22,652 · 2024 $46,265 · 2025 $27,520
Speaker / faculty: $24,767Food & beverage: $2,040Travel & lodging: $713
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 25 | $18,703 |
| GENZYME CORPORATION | 4 | $7,787 |
| ABBVIE INC. | 9 | $256 |
| UCB, Inc. | 4 | $235 |
| Galderma Laboratories, L.P. | 2 | $208 |
| Novartis Pharmaceuticals Corporation | 8 | $164 |
| Arcutis Biotherapeutics, Inc. | 4 | $64 |
| Lilly USA, LLC | 3 | $61 |
| Organon LLC | 1 | $22 |
| Amgen Inc. | 1 | $20 |
Products named: DUPIXENT, RINVOQ, NEMLUVIO, COSENTYX, Zoryve, EBGLYSS, Bimzelx, NEXPLANON.
Industry payments across PA — which companies pay providers there.
